Ex-PI firm set to leave nearly £40m of debts unpaid


Debts: Unsecured creditors to receive pennies

The outlook for creditors of failed personal injury firm Roberts Jackson has worsened, with nearly £40m that it owes, more than half to its private equity backer, unlikely to be paid.

The industrial disease specialist was sold to Manchester firm AWH Legal in a pre-pack in September 2018 and it later emerged that a dispute with its former after-the-event insurer was the key factor in the firm becoming insolvent.

The book value of the work in progress bought by AWH was £13.4m, plus debtors, disbursements and accrued revenue totalling just over £6m.

AWH is paying 10% of all profit costs and success fees from settled cases, 50% of the recoverable value of disbursements, 90% of debtors and 60% of accrued income.

The latest update from the joint administrators at Quantuma said they have so far recovered nearly £1.2m and in the best-case scenario this would eventually reach £3.5m.

Roberts Jackson had a £4.25m revolving credit facility with NatWest, secured by way of a debenture incorporating fixed and floating charges. Quantuma estimated that, at best, the bank would recover 56% of this, and at worst 42%, lower figures than earlier on in the administration.

However, the private equity firm NorthEdge Capital, which initially invested £15m in 2014, will not receive any of the £22.5m it is owed, in line with Quantuma’s earlier forecast.

Unsecured creditors – who by law are entitled to a proportion of the proceeds where there is a creditor with a floating charge – were estimated at £13.7m, including £6m to medico-legal agencies. Counsel and other legal advisers were owed £2.4m.

Quantuma has so far received 109 claims from unsecured creditors worth £7.5m, and anticipated the dividend would be in the range of 3.2-4.2p in the pound.

It submitted a confidential report to the Insolvency Service last year following its statutory investigation into the conduct of Roberts Jacksons’ directors.

Quantuma is being paid £45,000 plus 3.5% of the value of the total assets realised.




Blog


Does the Lloyd review mark the end of the Legal Services Act?

The Legal Services Board often generates eye-rolls and irritation from the leaders of the frontline regulators it oversees and of the representative bodies attached to them.


A familiar story?

There is no doubt that the rising cost of clinical negligence claims deserves attention. However, the system’s true cost driver is often not the claim itself.


When AI becomes a line on the client’s bill

On 23 June, Legora changed how it charges. The platform announced that its most capable product was moving away from a flat per-seat licence fee to consumption-based pricing


Loading animation